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2Challenges to medical care during human space exploration
• Real Time Communications
• Evacuation Capability (1.5 – 36 hrs)
• ‘Strong’ Consumables Resupply
• Large internal volume
• Near Real Time Communications
• Evacuation Capability (3-11 days)
• Limited Consumables Resupply
• Significant mass and volume constraints
• No Real Time Communications
• No Evacuation Capability
• No Consumables Resupply
• Very small spacecraft
Increasing exposure to Hazards
Advance medical system 
design and risk-informed 
decision-making for 
exploration beyond low Earth 
orbit to promote human health 
and performance in space
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Altered Gravity Field
1. Spaceflight-Associated Neuro-ocular 
Syndrome (SANS)
2. Renal Stone Formation 
3. Impaired Control of Spacecraft/Associated 
Systems and Decreased Mobility Due to 
Vestibular/Sensorimotor Alterations 
Associated with Space Flight
4. Bone Fracture due to spaceflight Induced 
changes to bone
5. Impaired Performance Due to Reduced 
Muscle Mass, Strength & Endurance
6. Reduced Physical Performance Capabilities 
Due to Reduced Aerobic Capacity 
7. Adverse Health Effects Due to Host-
Microorganism Interactions
8. Urinary Retention
9. Orthostatic Intolerance During Re-Exposure 
to Gravity
Concerns
1. Concern of Clinically Relevant Unpredicted 
Effects of Medication
2. Concern of Intervertebral Disc Damage upon 
and immediately after re-exposure to Gravity
Radiation
1. Risk of Space Radiation Exposure on 
Human Health:
• Acute solar events
• Cancer
• CNS impairment
• Tissue degeneration (cardio)
Isolation/Confinement
1. Adverse Cognitive or Behavioral Conditions 
& Psychiatric Disorders 
2. Performance & Behavioral health 
Decrements Due to Inadequate 
Cooperation, Coordination, 
Communication, & Psychosocial Adaptation 
within a Team
Hostile Closed Environment
1. Acute and Chronic Carbon Dioxide Exposure
2. Performance decrement and crew illness due 
to inadequate food and nutrition
3. Injury from Dynamic Loads
4. Injury and Compromised Performance due to 
EVA Operations
5. Adverse Health & Performance Effects of 
Celestial Dust Exposure
6. Adverse Health Event Due to Altered Immune 
Response
7. Reduced  Crew Performance Due to 
Hypobaric Hypoxia
8. Performance Decrements & Adverse Health 
Outcomes Resulting from Sleep Loss, 
Circadian Desynchronization, & Work 
Overload
9. Reduced Crew Performance Due to 
Inadequate Human-System Interaction 
Design 
10. Decompression Sickness
11. Toxic Exposure
12. Hearing Loss Related to Spaceflight
Key:  High LxC Medium LxC Low LxC  TBD LxC
Distance from Earth
1. Adverse Health Outcomes & Decrements in 
Performance due to inflight Medical 
Conditions 
2. Ineffective or Toxic Medications due to 
Long Term Storage
Human Health & Performance Risks
Likelihood and Consequence (LxC) linked to potential NASA Mars mission 
410 July 2019
ExMC’s Areas of Focus 
Scientific & 
Clinical 
Research
Technology 
Demonstrations
Systems 
Engineering
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Exploration evidence library
Clinical research 
Scientific publications
Concepts of operations
Requirements development
Medical system models
Trade space analysis
Autonomous procedures
Exploration lab analysis
Integrated, multifunctional devices
Translate medicine into engineering to enable medicine
ConOps, 
scenarios
7Habitat System
Ground System
Crew as 
Caregiver 
Crew as 
Explorer or 
Patient 
Structures Avionics & Software
Guidance, 
Navigation and 
Control
Comm & 
Tracking Power etc.
Crew Health and Performance
Environmental 
Health
Crew 
Performance
Crew Health
and Wellness
MedOps
Medical
Crew Health and Performance Data
Integrating medical into a broader crew health and performance system
What is a “trade space analysis”?
• Rigorous exercise to identify 
the most acceptable solution 
amongst a set of alternative 
solutions
• Enables a traceable and 
repeatable process
• Evaluations will assess metrics 
for:
– Risk: Probabilities of loss of crew 
and loss of mission
– Resource characterizations: mass, 
power, volume, etc.
ExMC’s Need: 
Provide a data-driven means to 
inform human health and 
performance risk mitigation for 
resource-constrained exploration 
missions
• What if spacewalks are added to the mission 
parameters?  
• What if the mission were extended?
• What if mass allocation lowers by 25%?
• Which imaging technology is most useful?  
Ultrasound or X-ray? 
• What is the medical risk of reducing crew's water 
rations from 3L to 2L daily? 
IMPACT – trade space analysis tool suite
Key ExMC 2019 Accomplishments
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Pharmacy Stability Technical Interchange Meeting
ExMC held a Pharmacy Stability TIM in June 2019. The TIM:
• Uncovered a gap about potential impact of CO2
• Recommended prioritization scheme for medication study
• Kick started a collaboration with the FDA for stability data
• Created a path to a stability flight study 
MDA Participation in NASA 
Gateway Habitat Evaluations
ExMC Medical Data Architecture team 
successfully deployed MDA software 
in the Gateway Habitat Test 
Environment in support of engineering 
and crewed assessments of prototype 
habitats which were developed by 
multiple commercial companies. The 
integration of the medical data system 
into the habitat network helps NASA 
evaluate habitat prototypes through 
system tests which map to relevant 
mission scenarios and test objectives. 
Trade Study Evaluation Tool Suite (TSETS) 
• Completed all pilot studies
• Further integration of individual tools that make up the tool suite
• Developed post-processing tools to improve visualization
• Demonstrated the ability to perform medical system trades
• TSETS will now become IMPACT, adding additional capability
Cis-lunar Medical System 
Requirements
ExMC delivered medical 
system functional requirements 
recommendations that can be 
applied to future Gateway 
vehicles/missions.
Selected ExMC current efforts
• Continuing to use systems engineering principles and models to develop crew health and performance 
(includes medical system) functional requirements to enable full vehicle and mission integration, especially for 
Mars missions
• Initial assessment of potential clinical decision support tools for inclusion in the Medical Data Architecture 
(MDA)
• Refining the trade space analysis tools suite (IMPACT) that will allow for evidence-based, risk-informed 
decision making (with respect to human health and performance) when participating in the engineering system 
design process of new space vehicles and missions
• Complete assessment of potential medications to include in an exploration formulary using previously 
published information and new access to FDA data
• Technology demonstrations of medical capabilities that have the potential for inclusion in future exploration 
medical systems (blood analysis devices, autonomous ultrasound procedures, integrated multifunctional 
devices)
• Expanding and updated the evidence library that will be used by the next generation medical probabilistic risk 
analysis tool (MEDPRAT) and IMPACT
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Areas of Future ExMC Work
• Exploration pharmacy:
– Designing and executing a flight study to assess pharmaceutical stability of selected high-yield exploration 
medications
– Development of the Element strategy to evaluate the role of pharmacokinetics and pharmacodynamics in 
medication effectiveness during long-duration, long-distance spaceflight
• Clinical decision support tools to be used by astronauts autonomously:
– Determination of medical treatment/management plans
– Automated image/data analysis
– Differential diagnosis generation
• Deep space exploration medical system model:
– Refine Concept of Operations for medical care during Mars missions
– Develop evidence-based functional requirements and incorporate into system model
– Incorporate new medical technologies and capabilities into system model for trade space analysis
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Questions?
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kris.lehnhardt@nasa.gov benjamin.easter@nasa.gov
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